科士达(002518) - 2023 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2023 was ¥1,245,845,792.85, representing a 2.25% increase compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2023 was ¥190,816,893.64, a decrease of 16.57% year-over-year[5]. - The net profit excluding non-recurring gains and losses was ¥186,747,221.58, down 10.99% from the previous year[5]. - Basic earnings per share for Q3 2023 was ¥0.33, a decrease of 17.50% compared to the same period last year[8]. - Total operating revenue increased by 48.51% to CNY 4,068,371,628.33 compared to CNY 2,739,526,895.43 in the same period last year[18]. - The net profit for the current period reached CNY 716,130,909.98, a significant increase from CNY 457,559,600.56 in the previous period, representing a growth of approximately 56.4%[33]. - The total comprehensive income for the current period was CNY 716,055,767.97, compared to CNY 457,308,785.63 in the previous period, indicating an increase of about 56.5%[36]. Cash Flow - The operating cash flow for the year-to-date period increased by 66.17% to ¥655,773,435.31, primarily due to increased sales collections[13]. - The net cash flow from operating activities was 655,773,435.31, an increase from 394,649,763.28 in the previous period, representing a growth of approximately 66.1%[39]. - The cash inflow from operating activities included CNY 262,554,808.48 from tax refunds, compared to CNY 130,621,803.21 in the previous period, showing an increase of approximately 100.5%[37]. - The total cash outflow from investing activities was 565,160,689.29, compared to 2,275,188,499.79 in the previous period, indicating a significant decrease in investment expenditures[39]. - The cash received from investment recoveries was 295,894,635.75, a decrease from 2,391,278,661.87 in the previous period, suggesting a decline in investment returns[39]. Assets and Liabilities - Total assets as of the end of the reporting period were ¥6,890,780,768.40, reflecting a 10.78% increase from the previous year[8]. - The equity attributable to shareholders increased by 14.32% to ¥4,054,687,668.11 compared to the end of the previous year[8]. - Total liabilities rose to ¥2,749,147,508.72, compared to ¥2,607,527,510.13, marking an increase of around 5.4%[30]. - The total liabilities increased, with accounts payable rising by 33.88% to CNY 1,056,273,207.41, attributed to increased inventory procurement[18]. - The company reported a significant decrease in short-term borrowings, down 100% to CNY 0.00 from CNY 64,840,063.27, due to repayment of loans[18]. Research and Development - Research and development expenses rose by 48.81% to CNY 153,950,323.01, driven by higher personnel costs and material usage[18]. - Research and development expenses rose to CNY 153,950,323.01, up from CNY 103,452,192.61, reflecting a growth of approximately 48.8%[33]. Strategic Plans - The company plans to continue focusing on market expansion and new product development in the upcoming quarters[10]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[19]. - The company has plans for market expansion and new product development to sustain growth momentum in the upcoming quarters[32]. - The company is focusing on enhancing its technological capabilities and exploring potential mergers and acquisitions to drive future growth[32]. Other Financial Metrics - The company reported a significant increase in non-operating income, which rose by 351.87% to ¥353,291.39 due to compensation and insurance refunds[13]. - The company experienced a 283.03% decrease in cash flow from investing activities, primarily due to reduced purchases of financial products[13]. - The company’s investment income decreased by 98.96% to CNY 199,067.22, mainly due to reduced returns from financial products[18]. - The company recorded a financial income of CNY 20,619,214.69, a significant increase from CNY 4,117,649.86 in the previous period, representing a growth of approximately 400.0%[33]. - The total sales expenses increased to CNY 239,192,059.43 from CNY 164,405,009.15, reflecting a rise of about 45.4%[33].